Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,610.00
9 (0.35%)
BSENSE

Aug 11

BSE+NSE Vol: 16.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ajanta Pharma
Gland Pharma
Emcure Pharma
Ipca Labs
Glenmark Pharma
Sai Life
Anthem Bioscienc
Wockhardt
Abbott India
Alkem Lab
Glaxosmi. Pharma
Why is Glaxosmithkline Pharmaceuticals Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.44%
EBIT Growth (5y)
14.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-1.21
Sales to Capital Employed (avg)
1.97
Tax Ratio
26.31%
Dividend Payout Ratio
93.21%
Pledged Shares
0
Institutional Holding
12.59%
ROCE (avg)
-239.91%
ROE (avg)
45.70%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
42
Industry P/E
37
Price to Book Value
19.45
EV to EBIT
32.14
EV to EBITDA
30.55
EV to Capital Employed
-85.92
EV to Sales
10.46
PEG Ratio
3.74
Dividend Yield
2.19%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
45.02%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NO KEY POSITIVE TRIGGERS
-3What is not working for the Company
PBT LESS OI(Q)

At Rs 278.69 cr has Fallen at -10.1% (vs previous 4Q average

PAT(Q)

At Rs 237.18 cr has Fallen at -7.1% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is not working for Glaxosmi. Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 278.69 cr has Fallen at -10.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 310.01 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 237.18 cr has Fallen at -7.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 255.19 Cr
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 43.76 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."